Advertisement

Topics

Vasculitis: Mepolizumab for eosinophilic granulomatosis with polyangiitis

05:03 EDT 3 Aug 2017 | Nature Publishing

Targeting IL-5 could improve outcomes and have steroid-sparing effects in the management of eosinophilic granulomatosis with polyangiitis. However, some questions remain about how this approach affects specific aspects of the disease.

Original Article: Vasculitis: Mepolizumab for eosinophilic granulomatosis with polyangiitis

NEXT ARTICLE

More From BioPortfolio on "Vasculitis: Mepolizumab for eosinophilic granulomatosis with polyangiitis"

Quick Search
Advertisement